Blood 3: Drugs acting on the blood and blood elements Flashcards
(93 cards)
Fibrinolysis represents the physiological converse of the ___________ process. It serves as a _______ mechanism against _______ of the coagulation mechanism
coagulation, defense, overactivity
Pro-coagulants factors _______ coagulation. They include the following:
promote, XIIa; XIa; Xa, IXa and thrombin (IIa)
Anti-coagulants ______ coagulation. They include the following:
inhibit, Fibrinolysis, antithrombin III (AT)
Fibrinolysis is the ________ breakdown of the fibrin in blood _____.
enzymatic, clots
When plasminogen is activated by local agents, such as tissue plasminogen activator, factors 11a and 12 a oplay a role in plasminogen becoming plasmin. Activated palsmin cuts polymerzied fibrin into fibrno degradation products.
Pharmacological acceleration of fibrinolysis involves these drugs that enhance the conversion of ________ to the active _______ plasmin
plasminogen, fibrinolytic
Fibrinolytic drugs are used as a form of emergency treatment in people for ______ ischemic ______, myocardial ________, deep vein ________, and pulmonary _________.
acute, strokes, infarction, thrombosis, thromboembolism
Plasmin in _______ blood –> increase in systemic bleeding.
peripheral
The use of Fibrinolytic drugs is not very successful in animals:
Used in these cases though:
▪ Feline arterial thromboembolism
▪ Canine pulmonary thromboembolism
Two drugs that are fibrinolytic drugs are:
❑ Streptokinase
❑ Recombinant tissue plasminogen activator (rt-PA)
rt-PA binds to fibirn in clots ad converts local fibrinogen into fibrin?
Fibrinolytic drugs actively reduce the ____ of a clot, as opposed to heparins, which inhibit the _____ of a clot
size, growth
rt-PA = local (attractive property)
Streptokinase is obtained from ?
β-hemolytic streptococci. often carried in intestines or lower intestinal tract. Generally unharmful in healthy adults.
Streptokinase is classified as:
Classification:
Pharmacologic = _________ activator
Therapeutic = _________ medication and enzyme
plasminogen, thrombolytic
Streptokinase MOA
Combines with ____________ to form ___________ complexes, then converts __________ to _________, which is then able to degrade clot-bound ___.
plasminogen, activator, plasminogen, plasmin, fibrin
Streptokinase Therapeutic effects:
▪ Lysis of thrombi in ______ arteries (heart attack)(_____)
▪ Lysis of pulmonary ____ and subsequent _____ of blood flow (____)
▪ Deep venous ______ in dog
coronary, cats, emboli, restoration, dogs, thrombosis
Streptokinase can be administered
IV
The adverse effects of Streptokinase include:
▪ __________ fibrinolysis
▪ ________________
▪ Serious __________
▪Metabolic _______, ________ and other complications may lead to death.
Systemic, Coagulopathy, hemorrhage, acidosis, bleeding
What can be seen here?
Streptokinase
Recombinant tissue plasminogen activator (rt-PA)
Is a _______ chain polypeptide ____ _____ with a higher ______ for fibrin within _____ and low affinity for ______ plasminogen (______ fibrinolysis)
single, serine, protease, specificity, thrombi, circulating, local
Pros of rt-PA ?
less systemic bleeding problems
rt-PA
Experience in animals is ________ and the optimal dosage is not ____
Cats: high mortality rate with ___ administration
Dogs: ______ cases
limited, known, IV, isolated
rt-PA
Adverse effects:
▪ Serious ______
▪ Potentially ______ in animals because it is a human protein
bleeding, antigenic
Excessive fibrinolysis can lead to _________ ______ disorders. Antifibrinolytic drugs are used to promote ________ and ______ the need for RBC transfusion
excessive, bleeding, hemostasis, decrease